Takeda's Gout Drug IP Case Paused After Deal With Watson
A Delaware federal judge on Tuesday pushed pause on Takeda's patent infringement suit seeking to block Watson Laboratories from producing a generic version of the gout treatment Colcrys after the parties...To view the full article, register now.
Already a subscriber? Click here to view full article